Dose-adjusted enoxaparin thromboprophylaxis in hospitalized cancer patients: a randomized, double-blinded multicenter phase 2 trial

Hospitalized patients with cancer are at an increased risk of developing venous thromboembolism (VTE). The recommendation for routine pharmacologic thromboprophylaxis in hospitalized patients with cancer to prevent VTE is based on extrapolation of results from noncancer cohorts. There are limited da...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Blood Adv
Hlavní autoři: Zwicker, Jeffrey I., Roopkumar, Joanna, Puligandla, Maneka, Schlechter, Benjamin L., Sharda, Anish V., Peereboom, David, Joyce, Robin, Bockorny, Bruno, Neuberg, Donna, Bauer, Kenneth A., Khorana, Alok A.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society of Hematology 2020
Témata:
Clinical Trials and Observations
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7252540/
https://ncbi.nlm.nih.gov/pubmed/32442298
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020001804
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky